Canaccord raised the firm’s price target on Exact Sciences to $75 from $70 and keeps a Buy rating on the shares. The analyst said we think the company is nicely positioned for a solid year in which Exact’s attractive fundamentals should be on full display amid key data readouts for important pipeline products.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on EXAS: